Skip to main content
GetTested
Lp(a) Test: What Lipoprotein(a) Is and Who Should Test Once
Article

Lp(a) Test: What Lipoprotein(a) Is and Who Should Test Once

Learn what lipoprotein(a) is, how genetics affect it, who should get an Lp(a) test, and why one measurement is often enough for adults.

11 min read

Authored by

Isabell Pamukci

Medical Content Specialist

Updated

By Isabell Pamukci·11 min read

Lp(a) Test: What Lipoprotein(a) Is and Who Should Test Once

Lipoprotein(a), usually written as Lp(a), is an inherited cardiovascular risk marker that a standard cholesterol panel usually does not measure. Knowing your level can add useful information even when your LDL cholesterol looks reassuring.

The main takeaway: the National Lipid Association recommends measuring Lp(a) at least once in every adult. Because levels are largely determined by genetics and are usually relatively stable, most adults do not need annual testing.

This guide is informational and is not a substitute for professional medical advice. Discuss testing decisions and results with a licensed healthcare provider.

What is Lp(a)?

Short answer: Lp(a), pronounced “L-P-little-a,” is a cholesterol-carrying particle in the blood that resembles LDL but has an additional protein attached. Higher levels contribute to the risk of atherosclerotic cardiovascular disease and calcific aortic valve disease.

  • Evidence: Genetic, observational, and mechanistic research supports a causal role for elevated Lp(a) in atherosclerotic cardiovascular disease and aortic valve stenosis.
  • Exceptions: An elevated level does not mean that you have cardiovascular disease or will definitely develop it. Overall risk depends on many factors.
  • Sample type: Blood; clinical laboratories commonly measure Lp(a) in serum or plasma obtained from venous blood.
  • Relevant test: Lp(a) Test – Genetic Heart Risk Marker.
  • Medical source: European Atherosclerosis Society: 2022 Lp(a) consensus statement.

Lipoproteins transport cholesterol and other fats through the bloodstream. Like LDL, an Lp(a) particle contains apolipoprotein B, or apoB. What distinguishes Lp(a) is a second protein called apolipoprotein(a), attached to the LDL-like particle.

Lp(a) can contribute to cholesterol buildup in artery walls and carries oxidized phospholipids involved in inflammation. It is also linked to calcification and narrowing of the aortic valve, which regulates blood flow from the heart into the aorta.

People sometimes search for “lipoprotein a,” but the laboratory name is usually lipoprotein(a) or Lp(a). It is not the same as apolipoprotein A-I, a protein associated with HDL cholesterol.

An Lp(a) test measures a risk marker. It does not show whether an artery is blocked, assess how narrowed a heart valve is, or diagnose a heart attack.

Is Lp(a) genetic?

Short answer: Yes. Lp(a) levels are largely inherited, particularly through variation in the LPA gene, and are much less influenced by diet or exercise than many other cardiovascular risk markers.

The LPA gene helps determine the structure of apolipoprotein(a) and how much Lp(a) circulates in the blood. Different inherited versions of this gene can produce substantial differences between individuals, including people in the same family.

“Genetic heart risk marker” does not mean the test sequences your DNA. Measuring the circulating Lp(a) level is usually more directly useful for routine risk assessment than looking for a particular genetic variant.

A high result is not evidence that someone has eaten poorly or failed to exercise. Likewise, being physically active, having a healthy body weight, or having favorable cholesterol results does not exclude elevated Lp(a).

Average levels differ across ancestry groups, but ancestry cannot reliably predict an individual result. Elevated Lp(a) can occur in any population. This is one reason current specialty guidance supports broad adult testing rather than testing only people with a particular background.

Who should get an Lp(a) test, and how often?

Short answer: The National Lipid Association recommends at least one Lp(a) measurement in every adult. Testing is particularly informative for people with early cardiovascular disease, familial hypercholesterolemia, or a family history of elevated Lp(a) or premature cardiovascular disease.

  • Evidence: The 2024 National Lipid Association focused update recommends measuring Lp(a) at least once in every adult for risk stratification. The 2022 European Atherosclerosis Society consensus also supports at least once-in-adulthood testing.
  • Exceptions: Children are generally considered for selective testing rather than universal screening. Repeat adult testing may be appropriate when a result is uncertain or the clinical situation changes.
  • Sample type: Blood, typically venous serum or plasma; confirm the collection method for the specific service you choose.
  • Relevant test: Lp(a) Test – Genetic Heart Risk Marker.
  • Medical source: National Lipid Association: 2024 focused update on Lp(a) in clinical practice.

A routine preventive visit or cholesterol assessment is a practical opportunity to discuss a first measurement. There is no need to wait for symptoms: elevated Lp(a) itself usually does not cause noticeable symptoms.

Testing deserves particular attention when there is:

  • A personal history of a heart attack, ischemic stroke, or peripheral artery disease, especially at a younger age.
  • A family history of premature atherosclerotic cardiovascular disease—commonly defined as occurring before age 55 in men or 65 in women.
  • A parent, sibling, or child with elevated Lp(a).
  • Known or suspected familial hypercholesterolemia.
  • Uncertainty about cardiovascular risk after reviewing conventional risk factors.

For most adults, a reliable baseline result remains useful for years. Annual testing generally adds little because Lp(a) is not usually a short-term lifestyle-monitoring marker.

However, “test once” is not an absolute rule. A clinician may repeat a measurement if the initial result was obtained during pregnancy, significant illness, or a condition affecting Lp(a); if it is unexpected or close to a decision threshold; or if monitoring is needed for a specific clinical reason.

Recommendations can differ between professional organizations and healthcare systems. A specialty-society recommendation does not automatically establish insurance coverage or require the same testing approach for every patient.

Should relatives and children be tested if Lp(a) is high?

Short answer: First-degree relatives of someone with elevated Lp(a) should discuss testing with their healthcare provider. Testing children is selective and is best coordinated with a pediatric clinician.

  • Evidence: Current consensus supports family or “cascade” testing because elevated Lp(a) often clusters in families. The National Lipid Association identifies selected higher-risk children as candidates for testing.
  • Exceptions: A relative’s result does not determine your own level. Pediatric testing requires age-appropriate interpretation and should not be assumed to follow adult purchasing or testing pathways.
  • Sample type: Blood, with pediatric collection arranged through an appropriate clinical service.
  • Medical source: National Lipid Association: adult, pediatric, and family Lp(a) testing recommendations.

First-degree relatives include parents, siblings, and children. Sharing an elevated result with family members can help them recognize that this may be relevant to their own preventive care.

For children, reasons to consider testing include familial hypercholesterolemia, a first-degree relative with elevated Lp(a), a family history of premature atherosclerotic cardiovascular disease, or an unexplained ischemic stroke.

A childhood measurement does not necessarily replace adult reassessment. Levels can change during development, and the timing of any repeat measurement depends on the child’s circumstances. Consumer test availability should not be taken as evidence that a service is suitable for minors.

What do Lp(a) results mean, and why do the units matter?

Short answer: Higher Lp(a) generally means greater cardiovascular risk, but the result must be interpreted alongside other risk factors. Check whether the laboratory reports nmol/L or mg/dL; these units are not interchangeable.

The commonly used categories are:

  • Lower Lp(a)-related risk: below 75 nmol/L, or below 30 mg/dL.
  • Intermediate Lp(a)-related risk: 75 to less than 125 nmol/L, or 30 to less than 50 mg/dL.
  • High Lp(a)-related risk: at least 125 nmol/L, or at least 50 mg/dL.

These paired thresholds are guideline categories, not exact mathematical conversions. The unit nmol/L reflects particle concentration, while mg/dL reflects mass. Because apolipoprotein(a) varies in size, there is no single reliable conversion factor for every person. Avoid using an online calculator to convert your result for clinical decisions.

The meaning of an elevated result also depends on age, blood pressure, smoking, diabetes, LDL cholesterol, kidney function, and existing cardiovascular disease. A younger person may have a low estimated 10-year risk while still having meaningful lifetime risk associated with elevated Lp(a).

A licensed clinician can place the number in context. The laboratory flag alone is not a diagnosis or a complete cardiovascular assessment.

Is an Lp(a) test included in a standard cholesterol panel?

Short answer: Usually not. A standard lipid panel generally reports total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides; Lp(a) usually needs to be specifically ordered.

Normal LDL cholesterol does not rule out elevated Lp(a). Conversely, measuring Lp(a) does not replace a standard lipid panel: the tests answer related but different questions.

An apoB measurement is also not a substitute. Although Lp(a) particles carry apoB, a total apoB result does not separately identify the Lp(a) concentration.

Before ordering another panel, check your existing laboratory report for “lipoprotein(a)” or “Lp(a).” If it has already been measured under suitable circumstances, bringing that result to your clinician may be more useful than automatically repeating it.

How do you prepare for an Lp(a) test, including at-home testing?

Short answer: Fasting is generally not required for Lp(a) alone. Follow the specific collection instructions, because other tests ordered at the same time may have different preparation requirements.

  • Evidence: Lp(a) is generally suitable for nonfasting measurement. Reliable testing also depends on appropriate collection, sample handling, and laboratory analysis.
  • Exceptions: Combined panels may require fasting. Pregnancy, significant illness, and certain medical conditions may affect interpretation or the preferred timing.
  • Sample type: Lp(a) is measured in blood. Confirm whether the particular service uses venous collection or a validated capillary collection method; do not assume a finger-prick dried blood spot is accepted.
  • Relevant test: Lp(a) Test – Genetic Heart Risk Marker, analyzed in a CLIA-certified, CAP-accredited laboratory.
  • Medical source: European Atherosclerosis Society: measurement considerations; FDA: home-use tests.

The product information supplied for this guide does not specify the collection method. Check the current product instructions before ordering, including any age restrictions, shipping requirements, and provider involvement.

CLIA certification and CAP accreditation apply to the laboratory, not to the test itself. They do not mean that every result is error-free or establish FDA review of a particular test.

Direct-to-consumer laboratory testing is restricted in some states, and availability can depend on where you live. The listed Lp(a) product is HSA/FSA eligible; check with your plan administrator.

What should you discuss with your clinician after a high Lp(a) result?

Short answer: Discuss how the result changes your overall cardiovascular risk assessment and whether family testing is appropriate. Elevated Lp(a) is a reason for an individualized clinical review, not proof of existing disease.

  • Evidence: Consensus guidance emphasizes assessing elevated Lp(a) alongside established cardiovascular risk factors and considering family screening.
  • Exceptions: The appropriate follow-up differs for someone with established cardiovascular disease versus someone without it. Repeat measurement or additional evaluation is not automatically necessary for everyone.
  • Sample type: Review the original blood result, including its units; any further testing should answer a specific clinical question.
  • Medical source: European Atherosclerosis Society: clinical implications of elevated Lp(a).

Useful questions include whether the result was obtained under stable conditions, how it affects estimated lifetime risk, and whether a parent, sibling, or child should discuss testing with their own provider.

Lifestyle changes usually have little direct effect on Lp(a), but cardiovascular health is not determined by Lp(a) alone. Blood pressure, smoking, LDL cholesterol, blood sugar, and physical activity remain relevant to overall risk. An inherited marker does not make those factors unimportant.

Do not use a consumer laboratory result to make medication changes. A licensed clinician can explain what the result means for your care and whether specialist input would be useful.

Bottom line: For many adults, one Lp(a) test can fill an important gap in cardiovascular risk assessment. Its value comes from understanding inherited risk in context—not from repeatedly chasing the number.

Can you lower lipoprotein(a)?

Short answer: Some medical therapies can lower Lp(a), but lowering the number is not automatically the same as reducing cardiovascular events. A clinician can explain how the evidence applies to your overall risk.

  • Evidence: PCSK9 inhibitors can modestly reduce Lp(a) while substantially lowering LDL cholesterol. Lipoprotein apheresis also lowers Lp(a), but it is a specialized procedure reserved for selected patients.
  • Exceptions: Statins may leave Lp(a) unchanged or slightly increase it, even though they reduce cardiovascular risk in appropriate patients. An Lp(a) result alone should not guide medication changes.
  • Sample type: Blood; when monitoring is clinically appropriate, consistent laboratory methods and reporting units help interpretation.
  • Relevant test: Lp(a) Test – Genetic Heart Risk Marker measures the circulating level; it does not lower it or determine which therapy is appropriate.
  • Medical source: European Atherosclerosis Society: Lp(a), cardiovascular risk, and therapeutic evidence.

A key distinction is whether an intervention lowers a laboratory marker, reduces heart attacks or strokes, or does both. For example, niacin can lower Lp(a), but clinical trials have not established cardiovascular benefit from adding it to contemporary care, and adverse effects are a concern. A claim that a supplement “lowers Lp(a)” therefore does not establish that it improves heart health.

Therapies that specifically target production of apolipoprotein(a) have been studied in clinical trials. Large reductions in Lp(a) in a trial should not be interpreted as proof of fewer cardiovascular events without corresponding outcome evidence. Your clinician can review the latest findings and regulatory status.

This information is educational and is not a substitute for professional medical advice. Discuss results and questions about Lp(a)-lowering therapies with a licensed healthcare provider.

Frequently asked questions

What is Lp(a)?

Lp(a), or lipoprotein(a), is an LDL-like blood particle with an additional protein called apolipoprotein(a). Elevated levels contribute to cardiovascular risk and are associated with calcific aortic valve disease.

Is Lp(a) genetic?

Yes. Lp(a) levels are largely determined by inherited variation in the LPA gene. A routine Lp(a) test measures the blood particle rather than sequencing your DNA.

Who should get an Lp(a) test?

The National Lipid Association recommends at least one measurement in every adult. Testing is particularly informative with premature cardiovascular disease, familial hypercholesterolemia, or a family history of elevated Lp(a).

How often should Lp(a) be tested?

One reliable adult measurement is often sufficient because levels are generally stable. A clinician may recommend repeating it when the original result is uncertain, medical circumstances change, or there is a specific monitoring reason.

Can Lp(a) be high if LDL cholesterol is normal?

Yes. A reassuring LDL cholesterol result does not exclude elevated Lp(a). Standard cholesterol panels usually do not separately measure Lp(a).

Do you need to fast for an Lp(a) test?

Usually not for Lp(a) alone. Follow the collection instructions, since other tests ordered at the same time may require fasting.

Recommended reads